AXIN1 and hepatocellular carcinoma: Previous studies have linked the occurrence of AXIN1 mutations in HCC to inactivation of the Hippo signaling pathway and concomitant hyperactivity of YAP/TAZ-mediated transcription, although the underlying mechanisms have remained incompletely understood.10